Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This article (A59374) is a billing and coding guidance document referencing LCD L39575 for amniotic and placental-derived product injections/applications for musculoskeletal, non-wound indications. The submitted text did not include the LCD or policy content itself, so specific indications, limitations, frequency limits, and required documentation could not be extracted—please provide the full LCD L39575 or policy text to enable complete structured extraction.

"This billing and coding article provides billing and coding guidance for Local Coverage Determination (LCD) L39575 regarding amniotic and placental-derived product injections/applications for muscu..."

Sign up to see full coverage criteria, indications, and limitations.